NeisVac-C (meningococcal group c polysaccharide conjugate vaccine adsorbed): Reviews and patient testimonials
Medication indications
NeisVac-C 0.5ml Suspension for injection in pre-filled syringe
NeisVac-C is indicated for active immunisation in children from 2 months of age, adolescents and adults, for the prevention of invasive disease caused by Neisseria meningitidis serogroup C.The use of NeisVac-C should be determined on the basis of official recommendations.Route of administration: Injectable
Molecule: meningococcal group c polysaccharide conjugate vaccine adsorbed
Patients' opinions on NeisVac-C
In brief
General satisfaction level: Be the first to evaluate
Treatment's effectiveness: Be the first to evaluate
Ease of use: Be the first to evaluate
Adherence to prescription: Be the first to evaluate
Detected side effects: Be the first to evaluate
Improvement in the quality of life: Be the first to evaluate
1 = Not at all satisfied
10 = Extremely satisfied
1 = Not at all satisfied
10 = Extremely satisfied
1 = Not at all satisfied
10 = Extremely satisfied
1 = Never
10 = Always
1 = Not at all important
10 = Extremely important
1 = Not at all satisfied
10 = Extremely satisfied
Tips and advice of the community
Join Carenity and be the first to give your opinion on this medication.